A Clinical Comparative Study of Two Different Endometrial Cell Samplers for Evaluation of Endometrial Lesions by Cytopathological Diagnosis

Cancer Manag Res. 2020 Oct 23:12:10551-10557. doi: 10.2147/CMAR.S272755. eCollection 2020.

Abstract

Purpose: Cytopathology detecting for endometrial cancer is becoming accepted, and Tao Brush is the most widely used sampler for endometrial cells. This study aims to compare the effectiveness between Li brushes and Tao brushes for the diagnosis of endometrial lesions and to evaluate the diagnostic accuracy of endometrial cytology compared with histology.

Methods: There were 109 patients needing dilation and curettage (D&C) and 21 patients needing hysterectomies included from November 2017 to April 2018. Every patient was sampled by Tao brush and Li brush before D&C or hysterectomy performed. The cytological results were compared based on the gold standard histological results of D&C or hysterectomy.

Results: The sensitivity of Li brush cytology for detecting endometrial cancer and atypical hyperplasia was estimated at 83.33%, specificity at 100%, positive predictive value (PPV) at 100%, and negative predictive value (NPV) at 98.02%, respectively. While for the Tao brush, it was 91.67% of sensitivity, 96.04% of specificity, 73.33% of PPV, and 98.98% of NPV, respectively. The kappa value was 0.767, which indicated a substantial agreement. Cytology by both two brushes had a lower insufficient sample rate (2.75% of Tao brush, 4.59% of Li brush) than did D&C (11.93%).

Discussion: Endometrial cytology is a reliable approach for evaluating endometrium with a lower insufficient sample rate. Cytology sampled by both Li brushes and Tao brushes has a high accuracy with histological diagnosis in detecting endometrial cancer and atypical hyperplasia. Combining social and economic benefits, the Li brush may be a better endometrial cell collector.

Keywords: Li brush; Tao brush; cytology; dilation and curettage; endometrial cancer.

Grants and funding

This work was supported by the Natural Science Basic Research Program of Shaanxi (Program No.2018JM7073/2017ZDJC-11), the Key Research and Development Program of Shaanxi (Program No.2017ZDXM-SF-068/2019QYPY-138), the Innovation Capability Support Program of Shaanxi (Program No.2017XT-026/2018XT-002), the Clinical Research Award of the First Affiliated Hospital of Xi’an Jiaotong University, China (Program No.XJTU1AF-2018-017/XJTU1AF-CRF-2019-002), and the Medical Research Project of Xi’an Social Development Guidance Plan (Program No.2017117SF/YX011-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.